Telavancin Observational Use Registry (TOUR)
| Status: | Completed |
|---|---|
| Conditions: | Pneumonia, Skin and Soft Tissue Infections, Cardiology, Infectious Disease, Infectious Disease |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 1/17/2019 |
| Start Date: | November 2014 |
| End Date: | October 2017 |
The telavancin observational use registry (TOUR) will collect data to support study of the
efficacy, safety, and pattern of use of telavancin in hospital-based inpatients and in
outpatients being treated in infusion centers who are receiving clinician directed telavancin
therapy.
efficacy, safety, and pattern of use of telavancin in hospital-based inpatients and in
outpatients being treated in infusion centers who are receiving clinician directed telavancin
therapy.
This is a retrospective medical chart review, multicenter, observational study to examine
telavancin efficacy and safety in a real-word setting and to characterize the pattern of use
of telavancin in hospital-based inpatients and in outpatient infusion centers. All treatment
decisions and clinical assessment will be made at the discretion of the treating physician
per usual care and are not mandated by study design or protocol.
telavancin efficacy and safety in a real-word setting and to characterize the pattern of use
of telavancin in hospital-based inpatients and in outpatient infusion centers. All treatment
decisions and clinical assessment will be made at the discretion of the treating physician
per usual care and are not mandated by study design or protocol.
Inclusion Criteria:
-received at least 1 dose of telavancin since January 1, 2015
Exclusion Criteria:
- Participation in an interventional research study or clinical trial involving
telavancin after January 01, 2015
We found this trial at
1
site
Southfield, Michigan 48075
Principal Investigator: Vilma Drelickman, MD
Phone: 248-552-0620
Click here to add this to my saved trials
